Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
14.58
-0.34 (-2.28%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Perrigo Company Market Cap
Perrigo Company has a market cap or net worth of $2.02 billion as of September 8, 2026. Its market cap has decreased by -35.08% in one year.
Market Cap
2.02B
Enterprise Value
5.10B
1-Year Change
-35.08%
Ranking
Category
Stock Price
$14.58
ChartMarket Cap Chart
Since December 1, 1998, Perrigo Company's market cap has increased from $622.50M to $2.02B, an increase of 225.02%. That is a compound annual growth rate of 4.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 2.02B | 5.62% |
| Dec 31, 2025 | 1.92B | -45.38% |
| Dec 31, 2024 | 3.51B | -19.56% |
| Dec 29, 2023 | 4.36B | -5.00% |
| Dec 30, 2022 | 4.59B | -11.80% |
| Dec 31, 2021 | 5.20B | -14.75% |
| Dec 31, 2020 | 6.10B | -13.19% |
| Dec 31, 2019 | 7.03B | 33.57% |
| Dec 31, 2018 | 5.26B | -57.12% |
| Dec 29, 2017 | 12.28B | 2.87% |
| Dec 30, 2016 | 11.93B | -43.67% |
| Dec 31, 2015 | 21.18B | -5.39% |
| Dec 31, 2014 | 22.39B | 54.74% |
| Dec 31, 2013 | 14.47B | 48.17% |
| Dec 31, 2012 | 9.77B | 7.71% |
| Dec 30, 2011 | 9.07B | 55.24% |
| Dec 31, 2010 | 5.84B | 60.58% |
| Dec 31, 2009 | 3.64B | 22.02% |
| Dec 31, 2008 | 2.98B | -8.90% |
| Dec 31, 2007 | 3.27B | 104.21% |
| Dec 29, 2006 | 1.60B | 15.06% |
| Dec 30, 2005 | 1.39B | 13.24% |
| Dec 31, 2004 | 1.23B | 11.97% |
| Dec 31, 2003 | 1.10B | 30.33% |
| Dec 31, 2002 | 842.80M | -3.10% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Supernus Pharmaceuticals | 2.47B |
| Bausch Health Companies | 2.40B |
| HUTCHMED (China) | 2.40B |
| Trulieve Cannabis | 2.39B |
| Prestige Consumer Healthcare | 2.36B |
| BioCryst Pharmaceuticals | 2.32B |
| Alvotech | 1.85B |
| Eton Pharmaceuticals | 1.70B |